Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Howard Seltman is active.

Publication


Featured researches published by Howard Seltman.


Biological Psychiatry | 2006

Evaluation of a Susceptibility Gene for Schizophrenia: Genotype Based Meta-Analysis of RGS4 Polymorphisms from Thirteen Independent Samples

Michael E. Talkowski; Howard Seltman; Anne S. Bassett; Linda M. Brzustowicz; Xiangning Chen; Kodavali V. Chowdari; David A. Collier; Quirino Cordeiro; Aiden Corvin; Smita N. Deshpande; Michael F. Egan; Michael Gill; Kenneth S. Kendler; George Kirov; Leonard L. Heston; Pat Levitt; David A. Lewis; Tao Li; Karoly Mirnics; Derek W. Morris; Nadine Norton; Michael Conlon O'Donovan; Michael John Owen; Christian Richard; Prachi Semwal; Janet L. Sobell; David St Clair; Richard E. Straub; B.K. Thelma; Homero Vallada

BACKGROUND Associations between schizophrenia (SCZ) and polymorphisms at the regulator of G-protein signaling 4 (RGS4) gene have been reported (single nucleotide polymorphisms [SNPs] 1, 4, 7, and 18). Yet, similar to other SCZ candidate genes, studies have been inconsistent with respect to the associated alleles. METHODS In an effort to resolve the role for RGS4 in SCZ susceptibility, we undertook a genotype-based meta-analysis using both published and unpublished family-based and case-control samples (total n = 13,807). RESULTS The family-based dataset consisted of 10 samples (2160 families). Significant associations with individual SNPs/haplotypes were not observed. In contrast, global analysis revealed significant transmission distortion (p = .0009). Specifically, analyses suggested overtransmission of two common haplotypes that account for the vast majority of all haplotypes. Separate analyses of 3486 cases and 3755 control samples (eight samples) detected a significant association with SNP 4 (p = .01). Individual haplotype analyses were not significant, but evaluation of test statistics from individual samples suggested significant associations. CONCLUSIONS Our collaborative meta-analysis represents one of the largest SCZ association studies to date. No individual risk factor arose from our analyses, but interpretation of these results is not straightforward. Our analyses suggest risk due to at least two common haplotypes in the presence of heterogeneity. Similar analysis for other putative susceptibility genes is warranted.


Journal of Pediatric Psychology | 2010

Brief Report: Trajectories of Glycemic Control over Early to Middle Adolescence

Vicki S. Helgeson; Pamela R. Snyder; Howard Seltman; Oscar Escobar; Dorothy J. Becker; Linda Siminerio

OBJECTIVES To identify distinct patterns of glycemic control over early to middle adolescence, and to determine whether psychosocial variables predicted those patterns. METHODS We used trajectory analysis to examine glycemic control over 5 years among adolescents with type 1 diabetes who were of age 12 on average at study start (n = 132). Well-being, relationships, and self-care behavior were assessed with in-person interviews. Blood glucose testing was determined from blood glucose meters, and missed clinic appointments and glycosolated hemoglobin were obtained from medical records. RESULTS We identified two distinct clusters of individuals, a stable good glycemic control group and a poorer deteriorating glycemic control group. Individuals in the deteriorating control group were characterized by higher peer conflict, more negative diabetes emotions, fewer blood glucose tests, and more missed clinic appointments. CONCLUSION Psychosocial variables and behavioral markers of self-care may predict the course of glycemic control over early to middle adolescence.


Gastroenterology | 1983

Budd-Chiari syndrome recurring in a transplanted liver

Howard Seltman; Andrew Dekker; David H. Van Thiel; Dane R. Boggs; Thomas E. Starzl

A patient with Budd-Chiari syndrome who underwent orthotopic liver transplantation and developed recurrent disease is described. The immediate postoperative period was complicated by multiple thrombotic episodes, followed by a period of apparent remission associated with the initiation of coumadin and persantine therapy. After discontinuation of such antithrombotic therapy in order to biopsy the liver, the patient experienced another series of clinically overt vascular thromboses and ultimately died of sepsis 15 mo posttransplantation after a prolonged and complicated terminal hospital course. At autopsy, recurrent Budd-Chiari syndrome as well as thromboses in numerous other organs was demonstrated.


Transplantation | 1986

CYCLOSPORINE METABOLISM AND PHARMACOKINETICS FOLLOWING INTRAVENOUS AND ORAL ADMINISTRATION IN THE DOG

Bruno Gridelli; Lenia Scanlon; Riccardo Pellicci; Real LaPointe; Andre M. DeWolf; Howard Seltman; Warren F. Diven; Byers W. Shaw; Thomas E. Starzl; Ajit Sanghvi

The influence of assay method on single dose cyclosporine (CsA) pharmacokinetics was studied in nine dogs receiving either i.v. or oral CsA. Samples were drawn from hepatic, portal, and systemic veins at various times after the dose and CsA levels were determined by radiommunoassay (RIA) and high-performance liquid chromatography (HPLC). Blood concentration-time data were analyzed by nonlinear least-squares regression, using two-compartment models. RIA/HPLC ratios for all samples were greater than one, and did not change significantly over time. The mean RIA/HPLC ratios for samples drawn from all three veins were higher after oral than i.v. doses of the drug (P<0.05). Area under the concentration-time curve (AUC) was higher and systemic clearance (Cls) lower than calculated on the basis of RIA results, regardless of the route of administration. AUC calculated for CsA metabolites (RIA-HPLC) was highest in the portal vein after an oral dose of CsA. Bioavailability was 20.4% and 27.0% when estimated using HPLC and RIA data, respectively. The mean CsA metabolite index (CMI), when calculated for hepatic, portal, or systemic vein, was greater when the drug was administered orally. The mean hepatic extraction ratio (HER) of the parent drug and for CsA metabolites was approximately 23% in i.v. and p.o. studies. These results suggest that the gastrointestinal tract may play a role in the metabolism of CsA when the drug is administered orally. In addition, if CsA metabolites not measured by HPLC have either toxic or immunosuppressive properties, the RIA assay may be more useful for monitoring patients.


Metabolism-clinical and Experimental | 1984

Properties of cholesterol 7α-hydroxylase in rat liver microsomal acetone powder

Ajit Sanghvi; Warren F. Diven; Howard Seltman; Randhir Paul; Marguerite Rizk

Rat liver microsomes were extracted with acetone, and a microsomal powder preparation was obtained. The cholesterol 7 alpha-hydroxylase activity of acetone powder was linear with time, the amount of protein, and the amount of cholesterol in human or rat serum. Unesterified lipoprotein cholesterol was also an effective substrate, and the Km values increased progressively from high-density lipoprotein (HDL) to low-density lipoprotein (LDL) to very-low-density lipoprotein (VLDL), suggesting that HDL-free-cholesterol was the better substrate.


Nutrition Research | 1985

Study of nutritional anemia in male residents of a chronic care facility

Judith P. Brody; Howard Seltman; Anthony Pontereri; John R. Krause; Viktor Stolc

Abstract Fifty male residents of a chronic care facility were evaluated for evidence of anemia and/or nutritional deficiencies of folate, B 12 , or iron. Anemia was present in 16%, of which 88% were≥80 years of age. Hemoglobin (=14.2 g/dl), serum iron (=64 ug/dl), and total iron binding capacity (=210 ug/dl) in all residents were significantly lower than age and sex-matched controls, while serum ferritin in the non-anemic residents (=89 ng/dl) was comparable to age-matched controls. Serum ferritin was significantly lower in the anemic compared to the non-anemic in whom a clinical or laboratory diagnosis was unclear. There was no evidence of folate or B 12 deficiency.


Clinical Chemistry | 1987

Critical issues in cyclosporine monitoring: report of the task force on cyclosporine monitoring

L. M. Sahw; L. Bowers; L. Demers; D. Freeman; T. Moyer; Ajit Sanghvi; Howard Seltman; Raman Venkataramanan


Transplantation proceedings | 1985

Biliary Excretion of Cyclosporine in Liver Transplant Patients.

Raman Venkataramanan; T.E. Starzl; Shuin Yang; Gilbert J. Burckart; Richard J. Ptachcinski; Byers W. Shaw; Shunzaburo Iwatsuki; D.H. Van Thiel; Amit N. Sanghvi; Howard Seltman


Clinical Chemistry | 1988

Abbott's fluorescence polarization immunoassay for cyclosporine and metabolites compared with the Sandoz "Sandimmune" RIA.

Ajit Sanghvi; Warren F. Diven; Howard Seltman; Thomas E. Starzl


Clinical Chemistry | 1982

Free thyroxine: a comparison of direct and indirect methods and their diagnostic usefulness in nonthyroidal illness.

Lehotay Dc; Wight Cw; Howard Seltman; Ajit Sanghvi; Levey Gs

Collaboration


Dive into the Howard Seltman's collaboration.

Top Co-Authors

Avatar

Ajit Sanghvi

University of Pittsburgh

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Byers W. Shaw

University of Nebraska Medical Center

View shared research outputs
Top Co-Authors

Avatar

David A. Lewis

University of Pittsburgh

View shared research outputs
Top Co-Authors

Avatar

Janet L. Sobell

University of Southern California

View shared research outputs
Top Co-Authors

Avatar

Kenneth S. Kendler

Virginia Commonwealth University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge